| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 17/12/2024 | 13:00 | PR Newswire (US) | Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians | NYSE:LH | Labcorp Holdings Inc |
| 04/12/2024 | 16:05 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NYSE:LH | Labcorp Holdings Inc |
| 03/12/2024 | 15:11 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NYSE:LH | Labcorp Holdings Inc |
| 02/12/2024 | 22:15 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NYSE:LH | Labcorp Holdings Inc |
| 26/11/2024 | 14:05 | PR Newswire (US) | Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients | NYSE:LH | Labcorp Holdings Inc |
| 19/11/2024 | 13:13 | Edgar (US Regulatory) | Form 8-K - Current report | NYSE:LH | Labcorp Holdings Inc |
| 19/11/2024 | 13:00 | PR Newswire (US) | Labcorp CFO Glenn Eisenberg Announces Plans to Retire | NYSE:LH | Labcorp Holdings Inc |
| 04/11/2024 | 15:00 | Business Wire | Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience | NYSE:LH | Labcorp Holdings Inc |
| 29/10/2024 | 16:35 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NYSE:LH | Labcorp Holdings Inc |
| 24/10/2024 | 12:50 | PR Newswire (US) | Labcorp Announces 2024 Third Quarter Results | NYSE:LH | Labcorp Holdings Inc |
| 18/10/2024 | 20:51 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] | NYSE:LH | Labcorp Holdings Inc |
| 16/10/2024 | 14:00 | Business Wire | NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S. | NYSE:LH | Labcorp Holdings Inc |
| 10/10/2024 | 14:30 | PR Newswire (US) | Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings with Rapid Syphilis Test | NYSE:LH | Labcorp Holdings Inc |
| 10/10/2024 | 12:50 | PR Newswire (US) | Labcorp Declares Quarterly Dividend | NYSE:LH | Labcorp Holdings Inc |
| 24/09/2024 | 22:16 | PR Newswire (US) | Labcorp to Announce Third Quarter Financial Results on October 24, 2024 | NYSE:LH | Labcorp Holdings Inc |
| 18/09/2024 | 13:00 | PR Newswire (US) | Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience | NYSE:LH | Labcorp Holdings Inc |
| 18/09/2024 | 12:12 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] | NYSE:LH | Labcorp Holdings Inc |
| 17/09/2024 | 00:35 | PR Newswire (US) | LABCORP PRICES $650,000,000 IN 4.350% SENIOR NOTES DUE 2030, $500,000,000 IN 4.550% SENIOR NOTES DUE 2032 AND $850,000,000 IN 4.800% SENIOR NOTES DUE 2034 | NYSE:LH | Labcorp Holdings Inc |
| 16/09/2024 | 23:30 | Edgar (US Regulatory) | Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses | NYSE:LH | Labcorp Holdings Inc |
| 16/09/2024 | 13:30 | PR Newswire (US) | Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health | NYSE:LH | Labcorp Holdings Inc |
| 03/09/2024 | 22:09 | PR Newswire (US) | Labcorp to Speak at the Baird 2024 Global Healthcare Conference | NYSE:LH | Labcorp Holdings Inc |
| 05/08/2024 | 13:00 | PR Newswire (US) | Labcorp Finalizes Acquisition of Select Assets of Invitae | NYSE:LH | Labcorp Holdings Inc |
| 02/08/2024 | 14:30 | PR Newswire (US) | Labcorp Receives FDA De Novo Marketing Authorization for PGDx elio™ plasma focus Dx | NYSE:LH | Labcorp Holdings Inc |
| 01/08/2024 | 12:57 | PR Newswire (US) | Labcorp Announces 2024 Second Quarter Results | NYSE:LH | Labcorp Holdings Inc |
| 30/07/2024 | 13:00 | PR Newswire (US) | Labcorp Expands Collaboration with Ultima Genomics to Advance Whole Genome Sequencing Applications and Oncology Testing Capabilities | NYSE:LH | Labcorp Holdings Inc |
| 01/07/2024 | 13:00 | PR Newswire (US) | Labcorp to Announce Second Quarter Financial Results on August 1, 2024 | NYSE:LH | Labcorp Holdings Inc |
| 17/06/2024 | 14:00 | PR Newswire (US) | Labcorp Launches Global Trial Connect to Accelerate Clinical Trials | NYSE:LH | Labcorp Holdings Inc |
| 03/06/2024 | 23:23 | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NYSE:LH | Labcorp Holdings Inc |
| 03/06/2024 | 13:00 | PR Newswire (US) | Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio | NYSE:LH | Labcorp Holdings Inc |
| 30/05/2024 | 19:18 | Edgar (US Regulatory) | Form SD - Specialized disclosure report | NYSE:LH | Labcorp Holdings Inc |